148 related articles for article (PubMed ID: 33692135)
1. Modular immune-homeostatic microparticles promote immune tolerance in mouse autoimmune models.
Chen X; Yang X; Yuan P; Jin R; Bao L; Qiu X; Liu S; Liu T; Gooding JJ; Chen W; Liu G; Bai Y; Liu S; Jin Y
Sci Transl Med; 2021 Mar; 13(584):. PubMed ID: 33692135
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice.
Carambia A; Freund B; Schwinge D; Bruns OT; Salmen SC; Ittrich H; Reimer R; Heine M; Huber S; Waurisch C; Eychmüller A; Wraith DC; Korn T; Nielsen P; Weller H; Schramm C; Lüth S; Lohse AW; Heeren J; Herkel J
J Hepatol; 2015 Jun; 62(6):1349-56. PubMed ID: 25617499
[TBL] [Abstract][Full Text] [Related]
3. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Kleist C; Mohr E; Gaikwad S; Dittmar L; Kuerten S; Platten M; Mier W; Schmitt M; Opelz G; Terness P
J Transl Med; 2016 May; 14(1):99. PubMed ID: 27131971
[TBL] [Abstract][Full Text] [Related]
4. In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
Kasagi S; Zhang P; Che L; Abbatiello B; Maruyama T; Nakatsukasa H; Zanvit P; Jin W; Konkel JE; Chen W
Sci Transl Med; 2014 Jun; 6(241):241ra78. PubMed ID: 24944193
[TBL] [Abstract][Full Text] [Related]
5. Intravenous Injection of Myelin Oligodendrocyte Glycoprotein-coated PLGA Microparticles Have Tolerogenic Effects in Experimental Autoimmune Encephalomyelitis.
Gholamzad M; Ebtekar M; Shafiee Ardestani M
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):271-281. PubMed ID: 28732440
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity.
Raverdeau M; Christofi M; Malara A; Wilk MM; Misiak A; Kuffova L; Yu T; McGinley AM; Quinn SM; Massilamany C; Reddy J; Forrester JV; Mills KH
EMBO Rep; 2019 May; 20(5):. PubMed ID: 30894405
[TBL] [Abstract][Full Text] [Related]
7. Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis.
LaMothe RA; Kolte PN; Vo T; Ferrari JD; Gelsinger TC; Wong J; Chan VT; Ahmed S; Srinivasan A; Deitemeyer P; Maldonado RA; Kishimoto TK
Front Immunol; 2018; 9():281. PubMed ID: 29552007
[TBL] [Abstract][Full Text] [Related]
8. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
al-Sabbagh A; Miller A; Santos LM; Weiner HL
Eur J Immunol; 1994 Sep; 24(9):2104-9. PubMed ID: 7522160
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis.
Faunce DE; Terajewicz A; Stein-Streilein J
J Immunol; 2004 Feb; 172(4):1991-5. PubMed ID: 14764660
[TBL] [Abstract][Full Text] [Related]
10. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ/Interleukin-27 Axis Induces Programmed Death Ligand 1 Expression in Monocyte-Derived Dendritic Cells and Restores Immune Tolerance in Central Nervous System Autoimmunity.
Casella G; Rasouli J; Thome R; Descamps HC; Vattikonda A; Ishikawa L; Boehm A; Hwang D; Zhang W; Xiao D; Park J; Zhang GX; Alvarez JI; Rostami A; Ciric B
Front Immunol; 2020; 11():576752. PubMed ID: 33193372
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific immune decoys intercept and exhaust autoimmunity to prevent disease.
Griffin JD; Song JY; Huang A; Sedlacek AR; Flannagan KL; Berkland CJ
Biomaterials; 2019 Nov; 222():119440. PubMed ID: 31450159
[TBL] [Abstract][Full Text] [Related]
13. Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.
von Kutzleben S; Pryce G; Giovannoni G; Baker D
Immunology; 2017 Apr; 150(4):444-455. PubMed ID: 27925187
[TBL] [Abstract][Full Text] [Related]
14. Screening Immunomodulators To Skew the Antigen-Specific Autoimmune Response.
Northrup L; Sullivan BP; Hartwell BL; Garza A; Berkland C
Mol Pharm; 2017 Jan; 14(1):66-80. PubMed ID: 28043135
[TBL] [Abstract][Full Text] [Related]
15. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
[TBL] [Abstract][Full Text] [Related]
16. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells.
Weiner HL
Microbes Infect; 2001 Sep; 3(11):947-54. PubMed ID: 11564443
[TBL] [Abstract][Full Text] [Related]
17. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells.
Yogev N; Frommer F; Lukas D; Kautz-Neu K; Karram K; Ielo D; von Stebut E; Probst HC; van den Broek M; Riethmacher D; Birnberg T; Blank T; Reizis B; Korn T; Wiendl H; Jung S; Prinz M; Kurschus FC; Waisman A
Immunity; 2012 Aug; 37(2):264-75. PubMed ID: 22902234
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity.
Umeshappa CS; Mbongue J; Singha S; Mohapatra S; Yamanouchi J; Lee JA; Nanjundappa RH; Shao K; Christen U; Yang Y; Ellestad KK; Santamaria P
J Clin Invest; 2020 Apr; 130(4):1823-1829. PubMed ID: 32125290
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis.
Miller SD; Tan LJ; Pope L; McRae BL; Karpus WJ
Int Rev Immunol; 1992; 9(3):203-22. PubMed ID: 1285061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
